Tunie serves as the Chief Financial Officer. She has 20 years of Finance experience, with over 10 years in the pharmaceutical industry. She was an integral part of the turnaround and growth of Par and its successful sale to Endo in 2015.
Most recently, Tunie was the Generics Business Controller for Endo Pharmaceuticals where she was responsible for generics consolidated financial statements, global policy and processes, and alliance management. She has worked on several key organizational-wide strategic initiatives including leading the finance integration for Par and a number of restructuring initiatives resulting in bottom line savings.
Tunie is a Certified Public Accountant in the state of New Jersey and holds a Bachelor’s degree in Accounting from Seton Hall University.